Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Autosomal recessive hypophosphatemic rickets (ARHR) is characterized by renal phosphate wasting, hypophosphatemia, normal serum calcium, and low 1,25-dihydroxyvitamin D. Dentin matrix protein 1 (DMP1) is an acidic extracellular matrix protein essential for bone mineralization and phosphate homeostasis (PMID:18037646). Loss-of-function variants in DMP1 disrupt phosphate regulation via fibroblast growth factor 23 (FGF23) up-regulation.
Genetic Evidence: A novel homozygous nonsense variant c.98G>A (p.Trp33Ter) was identified in two ARHR-affected siblings from a consanguineous Japanese family, with unaffected relatives heterozygous for the allele (PMID:20213538). A second kindred harbored biallelic large deletions and the Met1Val initiation codon variant, both leading to truncated DMP1 and elevated serum FGF23 (PMID:19007919).
In a cohort of 46 families with hypophosphatemic rickets, DMP1 variants were absent in 27 kindreds with PHEX and FGF23 mutations, underscoring the rarity of ARHR and the specificity of DMP1 loss-of-function in the recessive form (PMID:21050253).
Variant Spectrum & Segregation: Reported DMP1 variants include nonsense (e.g., c.98G>A (p.Trp33Ter)), splice-site, and large genomic deletions. No recurrent or founder alleles have been described. Segregation of homozygous LoF alleles with ARHR in two unrelated families provides strong genetic linkage.
Mechanism of Pathogenicity: Truncating DMP1 variants prevent secretion and proteolytic processing into active fragments. A transgenic mouse expressing a cleavage-resistant DMP1(D213A) mutant failed to rescue osteomalacia of Dmp1 knockout mice, demonstrating that proteolytic activation is essential for DMP1 function (PMID:20663874).
Animal Models: Transgenic mice expressing the human c.1484_1490del mutant in a Dmp1-null background displayed tooth hypomineralization and phosphate wasting similar to ARHR patients, confirming in vivo pathogenicity (PMID:20499360).
Conclusion: Biallelic loss-of-function DMP1 variants in at least two unrelated families, segregation data, and concordant in vitro and in vivo functional assays support a Moderate level of gene–disease association. ARHR due to DMP1 mutations should be considered in patients with hypophosphatemia, renal phosphate wasting, elevated FGF23, and normal calcium homeostasis.
Gene–Disease AssociationModerateBiallelic LoF DMP1 variants in two unrelated families with segregation and concordant functional data Genetic EvidenceModerate2 unrelated kindreds (3 affected individuals) with homozygous/compound heterozygous LoF variants and segregation evidence Functional EvidenceModerateIn vitro assays demonstrate defective DMP1 processing (PMID:20663874); transgenic mouse models recapitulate ARHR phenotype (PMID:20499360) |